Paul Tudor Jones Madrigal Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 1,900 shares of MDGL stock, worth $854,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,900
Previous 1,100
72.73%
Holding current value
$854,316
Previous $364,000
57.97%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MDGL
# of Institutions
356Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$985 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$940 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$896 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$888 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$844 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...